MENCEVAX AC PWS 500MCG/VIAL
MENCEVAX AC PWS 500MCG/VIAL
Discontinued
DIN Number
01962922
Drug Class
Human
Market Date
Aug 29, 1994
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number01962922
AIG Number0323419002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AH03 MENINGOCOCCUS, A, C, BIVALENT PURIFIED POLYSACC. ANTIGEN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationSubcutaneous
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (3)
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP AActive
Strength: 500 MCG / VIAL
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP CActive
Strength: 500 MCG / VIAL
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C
SODIUM CHLORIDEActive
Strength: 5 ML / VIAL
Monograph: SODIUM CHLORIDE